Evidence Level:Resistant: D – Preclinical
Title:
Oxysophocarpine suppresses FGFR1-overexpressed hepatocellular carcinoma growth and sensitizes the therapeutic effect of lenvatinib
Excerpt:These data collectively provided evidence that FGFR1 overexpression could be a potential cause of lenvatinib resistance...
DOI:10.1016/j.lfs.2020.118642